SGMO icon

Sangamo Therapeutics

182 hedge funds and large institutions have $315M invested in Sangamo Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 63 increasing their positions, 60 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

34% less capital invested

Capital invested by funds: $477M → $315M (-$162M)

43% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 30

Holders
182
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.18M
Puts
$639K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$48.2M
2
$44.1M
3
$39.7M
4
$30.7M
5
$12M
6
$10.5M
7
$9.15M
8
$8.63M
9
$7.83M
10
$6.66M
11
$4.91M
12
$4.41M
13
$4.32M
14
$4.04M
15
$3.92M
16
$3.75M
17
$3.63M
18
$3.5M
19
$3.41M
20
$3.37M
21
$3.33M
22
$3.24M
23
$3.19M
24
$2.71M
25
$2.57M